AG-348 Achieves Proof-of-Concept in Ongoing Phase 2 DRIVE-PK Study and Demonstrates Rapid and Sustained Hemoglobin Increases in Adults with Pyruvate Kinase Deficiency Read more about AG-348 Achieves Proof-of-Concept in Ongoing Phase 2 DRIVE-PK Study and Demonstrates Rapid and Sustained Hemoglobin Increases in Adults with Pyruvate Kinase Deficiency
Agios Reports Initial Data from Phase 1 Study of AG-519 in Healthy Volunteers Read more about Agios Reports Initial Data from Phase 1 Study of AG-519 in Healthy Volunteers
Agios to Host Conference Call from the 21st Congress of the European Hematology Association Read more about Agios to Host Conference Call from the 21st Congress of the European Hematology Association
Agios to Present Clinical and Preclinical Data from PKR Activators AG-348 and AG-519 at the 21st Congress of the European Hematology Association Read more about Agios to Present Clinical and Preclinical Data from PKR Activators AG-348 and AG-519 at the 21st Congress of the European Hematology Association
Agios Reports First Quarter 2016 Financial Results Read more about Agios Reports First Quarter 2016 Financial Results
Agios to Webcast Conference Call of First Quarter 2016 Financial Results on May 5, 2016 Read more about Agios to Webcast Conference Call of First Quarter 2016 Financial Results on May 5, 2016
Agios Announces Initiation of Phase 1/2 Frontline Combination Study of AG-221 or AG-120 with VIDAZA® (azacitidine for injection) in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Not Eligible for Intensive Chemotherapy Read more about Agios Announces Initiation of Phase 1/2 Frontline Combination Study of AG-221 or AG-120 with VIDAZA® (azacitidine for injection) in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Not Eligible for Intensive Chemotherapy
Agios to Present at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8 Read more about Agios to Present at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8
Agios Reports Fourth Quarter and Full Year 2015 Financial Results and Highlights Key 2016 Milestones Read more about Agios Reports Fourth Quarter and Full Year 2015 Financial Results and Highlights Key 2016 Milestones